Key points are not available for this paper at this time.
It’s time for the FDA to re-evaluate its decision to authorise Q-Collar, say James Smoliga and Mu Yang
Share your take
Add a clinician perspective alongside expert commentary.
Smoliga et al. (Thu,) studied this question.